115 related articles for article (PubMed ID: 25124624)
1. Risk factors of lymph node metastases with endometrial carcinoma.
Cetinkaya K; Atalay F; Bacinoglu A
Asian Pac J Cancer Prev; 2014; 15(15):6353-6. PubMed ID: 25124624
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for pelvic lymph node metastasis in endometrial cancer.
Li Y; Cong P; Wang P; Peng C; Liu M; Sun G
Arch Gynecol Obstet; 2019 Oct; 300(4):1007-1013. PubMed ID: 31435773
[TBL] [Abstract][Full Text] [Related]
3. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.
Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT
Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311
[TBL] [Abstract][Full Text] [Related]
4. Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer: Overtreatment Is the Main Issue.
Karalok A; Turan T; Basaran D; Turkmen O; Comert Kimyon G; Tulunay G; Tasci T
Int J Gynecol Cancer; 2017 May; 27(4):748-753. PubMed ID: 28301338
[TBL] [Abstract][Full Text] [Related]
5. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer.
Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S
Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal cytology in endometrial cancer.
Cetinkaya K; Atalay F
Tumori; 2015; 101(6):697-700. PubMed ID: 26350193
[TBL] [Abstract][Full Text] [Related]
7. Cervical invasion, lymphovascular space invasion, and ovarian metastasis as predictors of lymph node metastasis and poor outcome on stages I to III endometrial cancers: a single-center retrospective study.
Li M; Wu S; Xie Y; Zhang X; Wang Z; Zhu Y; Yan S
World J Surg Oncol; 2019 Nov; 17(1):193. PubMed ID: 31733657
[TBL] [Abstract][Full Text] [Related]
8. Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment.
Taşkın S; Şükür YE; Varlı B; Koyuncu K; Seval MM; Ateş C; Yüksel S; Güngör M; Ortaç F
Arch Gynecol Obstet; 2017 Oct; 296(4):803-809. PubMed ID: 28762064
[TBL] [Abstract][Full Text] [Related]
9. Factors predicting nodal metastasis in endometrial cancer.
Gilani S; Anderson I; Fathallah L; Mazzara P
Arch Gynecol Obstet; 2014 Dec; 290(6):1187-93. PubMed ID: 24981050
[TBL] [Abstract][Full Text] [Related]
10. A Predictive Model Using Histopathologic Characteristics of Early-Stage Type 1 Endometrial Cancer to Identify Patients at High Risk for Lymph Node Metastasis.
Bendifallah S; Canlorbe G; Laas E; Huguet F; Coutant C; Hudry D; Graesslin O; Raimond E; Touboul C; Collinet P; Cortez A; Bleu G; Daraï E; Ballester M
Ann Surg Oncol; 2015 Dec; 22(13):4224-32. PubMed ID: 25869227
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of gross myometrial invasion with endometrial cancer.
Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic factors in diagnosed endometrial cancers determining the type of radical surgery].
Ivanov S; Tomov S
Akush Ginekol (Sofiia); 2009; 48(3):14-9. PubMed ID: 20198758
[TBL] [Abstract][Full Text] [Related]
13. Association of Serum HE4 with Primary Tumor Diameter and Depth of Myometrial Invasion in Endometrial Cancer Patients at Rajavithi Hospital.
Prueksaritanond N; Cheanpracha P; Yanaranop M
Asian Pac J Cancer Prev; 2016; 17(3):1489-92. PubMed ID: 27039795
[TBL] [Abstract][Full Text] [Related]
14. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis.
Vargas R; Rauh-Hain JA; Clemmer J; Clark RM; Goodman A; Growdon WB; Schorge JO; Del Carmen MG; Horowitz NS; Boruta DM
Gynecol Oncol; 2014 May; 133(2):216-20. PubMed ID: 24548726
[TBL] [Abstract][Full Text] [Related]
15. [Clinical implications of positive peritoneal cytology in endometrial cancer].
Ren YL; Wang HY; Shan BE; Ping B; Shi DR
Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518
[TBL] [Abstract][Full Text] [Related]
16. Is Surgical Staging Necessary for Patients with Low-risk Endometrial Cancer? A Retrospective Clinical Analysis.
Kokcu A; Kurtoglu E; Celik H; Kefeli M; Tosun M; Onal M
Asian Pac J Cancer Prev; 2015; 16(13):5331-5. PubMed ID: 26225674
[TBL] [Abstract][Full Text] [Related]
17. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
Ivanov I
Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological factors predicting retroperitoneal lymph node metastasis and survival in endometrial cancer.
Tang X; Tanemura K; Ye W; Ohmi K; Tsunematsu R; Yamada T; Katsumata N; Sonoda T
Jpn J Clin Oncol; 1998 Nov; 28(11):673-8. PubMed ID: 9861234
[TBL] [Abstract][Full Text] [Related]
19. Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas.
Ytre-Hauge S; Husby JA; Magnussen IJ; Werner HM; Salvesen ØO; Bjørge L; Trovik J; Stefansson IM; Salvesen HB; Haldorsen IS
Int J Gynecol Cancer; 2015 Mar; 25(3):459-66. PubMed ID: 25628109
[TBL] [Abstract][Full Text] [Related]
20. To what extent is risk grouping method successful in deciding surgical staging in endometrial cancer?
Cetinkaya K; Atalay F; Bacinoglu A; Dervisoglu H
Tumori; 2016 Aug; 102(4):422-5. PubMed ID: 27032702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
